RayThera Raises $110 Million in Series A Financing
Financing will support advancement of preclinical immunology pipeline SAN DIEGO–(BUSINESS WIRE)–RayThera, Inc., a recently founded biotechnology company currently focused on discovering and developing small molecule therapies in immunology, announced today that it has completed its…